Neurotoxicity and Cardiotoxicity in Total Joint Arthroplasty

NCT ID: NCT04166539

Last Updated: 2021-12-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

115 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-10-01

Study Completion Date

2021-09-27

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research is to understand whether patients who previously had total hip or total knee replacement experience memory, thinking or heart problems. This study will help us determine if and how often these problems occur.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

At your first visit you will be asked to do the following.

* Sign this informed consent document.
* Questionnaire: You will be asked to complete a questionnaire about your family history of neurological diseases and current and past physical thinking activities.
* Interview: The interview will be performed by the study coordinator who is a member of the research team. It will take about 20-30 minutes to complete. You will be asked to answer questions about your general health, surgeries, medications, and your memory and thinking skills.
* Memory Interview: You will have an evaluation of your memory and thinking skills. You will answer questions and perform tasks that evaluate various thinking abilities such as concentration, memory, reasoning, and learning.
* Blood draw: Have a sample of blood drawn (4.2-5 tablespoons) for clinical and research tests.
* Magnetic Resonance Imaging (MRI) of your brain (optional): If you agree to participate, you will be asked to have MR imaging of your brain.
* Echocardiogram: You will be asked to have an echocardiogram of your heart.
* Follow-up visit in 2-3 years: You will be asked to return to Mayo for your second study visit in 2-3 years. At this visit, you will be asked to complete the same memory and thinking tests described for the first visit. You will also be asked to repeat the echocardiogram.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Metallosis Pain Total Hip Replacement Total Knee Replacement

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Revision Surgery Hip Knee Metals Metallosis Toxicity

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Metallosis Patients

Patients who are being seen by surgeons for metal-related issues in the blood, pain, or revision surgery.

Questionnaires

Intervention Type BEHAVIORAL

You will be asked to complete a questionnaire about your family history of neurological diseases and current and past physical thinking activities.

Interviews

Intervention Type BEHAVIORAL

Behavioral and Memory interviews will take place with the patient.

Blood draw

Intervention Type OTHER

Have a sample of blood drawn (4.2-5 tablespoons) for clinical and research tests.

Magnetic Resonance Imaging

Intervention Type RADIATION

Each MR examination takes about 45 minutes and does not require the use of needles, medication or contrast enhancement. You will lie on your back and enter the MR scanner for the study, during which time you will hear knocking noises. People with pacemakers, aneurysm clips, cochlear implants, or metal/foreign objects in their eyes are not permitted to undergo MR studies. We will review your implants and determine your eligibility.

Echocardiogram

Intervention Type DIAGNOSTIC_TEST

Each echocardiogram takes about 30 minutes. This test uses sound waves to look at your heart. The person doing the test will press on your chest with a machine to obtain the pictures. The pressure may be uncomfortable. The echocardiogram will involve an image enhancement agent infusion to obtain better images.

Control Group

Patients who have had total hip or knee arthroplasty no less than 5-10 years ago, who have no symptoms.

Questionnaires

Intervention Type BEHAVIORAL

You will be asked to complete a questionnaire about your family history of neurological diseases and current and past physical thinking activities.

Interviews

Intervention Type BEHAVIORAL

Behavioral and Memory interviews will take place with the patient.

Blood draw

Intervention Type OTHER

Have a sample of blood drawn (4.2-5 tablespoons) for clinical and research tests.

Magnetic Resonance Imaging

Intervention Type RADIATION

Each MR examination takes about 45 minutes and does not require the use of needles, medication or contrast enhancement. You will lie on your back and enter the MR scanner for the study, during which time you will hear knocking noises. People with pacemakers, aneurysm clips, cochlear implants, or metal/foreign objects in their eyes are not permitted to undergo MR studies. We will review your implants and determine your eligibility.

Echocardiogram

Intervention Type DIAGNOSTIC_TEST

Each echocardiogram takes about 30 minutes. This test uses sound waves to look at your heart. The person doing the test will press on your chest with a machine to obtain the pictures. The pressure may be uncomfortable. The echocardiogram will involve an image enhancement agent infusion to obtain better images.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Questionnaires

You will be asked to complete a questionnaire about your family history of neurological diseases and current and past physical thinking activities.

Intervention Type BEHAVIORAL

Interviews

Behavioral and Memory interviews will take place with the patient.

Intervention Type BEHAVIORAL

Blood draw

Have a sample of blood drawn (4.2-5 tablespoons) for clinical and research tests.

Intervention Type OTHER

Magnetic Resonance Imaging

Each MR examination takes about 45 minutes and does not require the use of needles, medication or contrast enhancement. You will lie on your back and enter the MR scanner for the study, during which time you will hear knocking noises. People with pacemakers, aneurysm clips, cochlear implants, or metal/foreign objects in their eyes are not permitted to undergo MR studies. We will review your implants and determine your eligibility.

Intervention Type RADIATION

Echocardiogram

Each echocardiogram takes about 30 minutes. This test uses sound waves to look at your heart. The person doing the test will press on your chest with a machine to obtain the pictures. The pressure may be uncomfortable. The echocardiogram will involve an image enhancement agent infusion to obtain better images.

Intervention Type DIAGNOSTIC_TEST

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

MRI

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patient is willing to sign consent
* Patients scheduled for revision surgery for osteolysis, aseptic loosening, or wear of TJA implants/ALTR.

OR

-MCSA (Mayo Clinic Study of Aging) patients with THA or TKA with at least 10 years since surgery.

Exclusion Criteria

* History of dementia
* History of cardiomyopathy or heart failure
* Revision for infection or fracture
* Patient is pregnant
* Patient has medication patches on
* Patient has a pacemaker or defibrillator (ICD)
* Patient has a deep brain stimulator (DBS)
* Patient has a vagal neuro stimulator (VNS)
* Patient has any other kind of neuro stimulator
* Patient has aneurysm clips in their head
* Patient has a tissue expander
* Patient has had a gastrointestinal clip or pill camera inserted in the last 90 days
* Patient has an esophageal reflux management system (LINX)
* Patient has a cochlear (ear) or auditory implant
* Patient has any implanted device (electronic or not) with magnets
* Patient has an eye injury involving metal
* Patient has allergy to contrast or dye
Minimum Eligible Age

18 Years

Maximum Eligible Age

100 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute on Aging (NIA)

NIH

Sponsor Role collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

Sponsor Role collaborator

Mayo Clinic

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Hilal Maradit Kremers

Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hilal Maradit Kremers, MD

Role: PRINCIPAL_INVESTIGATOR

Principal Investigator

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Mayo Clinic in Rochester

Rochester, Minnesota, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

R01AG060920

Identifier Type: NIH

Identifier Source: secondary_id

View Link

R01HL147155

Identifier Type: NIH

Identifier Source: secondary_id

View Link

19-001294

Identifier Type: -

Identifier Source: org_study_id